Inside-Filings
Projekt anfragen

SpyGlass Pharma, Inc. (SGP)

SpyGlass Pharma, Inc.
Healthcare · Biotechnology
TickerSGPBörseNasdaq
ISINUS85220G1094CIK0001778922
18,44
Schluss · 12.06.2026
1T+1,9 %1W−1,8 %1M−22,6 %3M−30,5 %
GCS 59 → +0,0
TSI -33,0 · -31,4 ▼ 15.05.
8-K 5.02 13.02.26· 123T
Insider ▲ 09.02.26· 127T
PDF

Glück Conviction Score™ ⓘ

SGP SpyGlass Pharma, Inc.
Conviction Score
59
Neutral
Effektiv: Neutral Niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
67,8
30 neu, 0 erhöht, 610,7M $ netto
Aktivist
97,2
13D-Filing vorhanden
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)

Score-Verlauf (90 Tage)

Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.

Kursverlauf (12 Monate)

Technische Indikatoren

27.5
Technical-Score: 27.5 / 100 (informativ, keine Anlageempfehlung)
Bullisch-Anteil 10 % — 1 bullisch / 6 bärisch / 3 neutral

Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).

IndikatorSignalGewichtWertDetailBeitrag
Kurs vs SMA50Bärisch10 %22.09-16.5 % vs SMA50
EMA20 vs EMA50Bärisch5 %19.76EMA50: 21.93
MACD-HistogrammBärisch10 %-0.029Bearisch
RSI(14)Neutral10 %35.4Neutral (30–70)
Stoch %K(14)Neutral5 %20.9Neutral
ADX(14)+DIBärisch10 %25.0+DI: 14.7 / −DI: 22.1
Z-Score(60)Bullisch5 %-1.72Extrem überverkauft
52W-PositionBärisch5 %4.0 %Hoch 29.68 / Tief 17.97
Bollinger(20,2σ)Neutral5 %28.3 %Upper 22.97 / Mid 19.81 / Lower 16.65
LinReg-Slope(60)Bärisch10 %-0.1039R²=0.56 / annualisiert -116.1 %

Insider-Transaktionen (12 Monate) ⓘ

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-02-09Nielsen Kirk G.DirectorOpen Market Purchase165.00016,002.640.000,00+20,3%
2026-02-09Vensana Capital I GP, LLC10% OwnerOpen Market Purchase165.00016,002.640.000,00+20,3%
2026-02-09SANDELL SCOTT D10% OwnerOpen Market Purchase937.50016,0015.000.000,00+115,1%
2026-02-09Makhzoumi Mohamad10% OwnerOpen Market Purchase937.50016,0015.000.000,00+115,1%
2026-02-09Florence Anthony A. Jr.10% OwnerOpen Market Purchase937.50016,0015.000.000,00+115,1%
2026-02-09Chang Carmen10% OwnerOpen Market Purchase937.50016,0015.000.000,00+115,1%
2026-02-09BASKETT FOREST10% OwnerOpen Market Purchase937.50016,0015.000.000,00+115,1%
2026-02-09Khan Bilal ArshadDirectorOpen Market Purchase20.00016,00320.000,00+2,5%
2026-02-09Khan Bilal ArshadDirectorOpen Market Purchase115.00016,001.840.000,00+14,1%
2026-02-09Pardo Geoffrey BDirectorOpen Market Purchase312.50016,005.000.000,00+38,4%
2026-02-09Walker Paul Edward10% OwnerOpen Market Purchase937.50016,0015.000.000,00+115,1%
2026-02-09Mathers Edward T10% OwnerOpen Market Purchase937.50016,0015.000.000,00+115,1%
2026-02-09Behbahani AliDirector, 10% OwnerOpen Market Purchase937.50016,0015.000.000,00+115,1%
2026-02-09Yang Rick10% OwnerOpen Market Purchase937.50016,0015.000.000,00+115,1%
2026-02-09New Enterprise Associates 17, L.P.10% OwnerOpen Market Purchase937.50016,0015.000.000,00+115,1%
2026-02-09RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerOpen Market Purchase248.03416,003.968.544,00+30,5%
2026-02-09RA CAPITAL MANAGEMENT, L.P.Director, 10% OwnerOpen Market Purchase3.441.96616,0055.071.456,00+422,7%

Fondsaktivität (Vorquartalsvergleich) ⓘ

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
RA CAPITAL MANAGEMENT, L.P.8.021.11708.021.117207.827.141Neu+100,0%
NEA Management Company, LLC7.392.30107.392.301191.534.519Neu+100,0%
Sands Capital Alternatives, LLC2.500.01202.500.01264.775.311Neu+100,0%
Samsara BioCapital, LLC2.109.95302.109.95354.668.882Neu+100,0%
Vestal Point Capital, LP666.7600666.76017.275.752Neu+100,0%
DEERFIELD MANAGEMENT COMPANY, L.P.550.0000550.00014.250.500Neu+100,0%
MILLENNIUM MANAGEMENT LLC468.7940468.79412.146.453Neu+100,0%
VANGUARD CAPITAL MANAGEMENT LLC434.8130434.81311.266.005Neu+100,0%
First Light Asset Management, LLC375.0000375.0009.716.250Neu+100,0%
FRANKLIN RESOURCES INC300.0000300.0007.773.000Neu+100,0%
Affinity Asset Advisors, LLC250.0000250.0006.477.500Neu+100,0%
Aberdeen Group plc220.4540220.4545.711.963Neu+100,0%
BlackRock, Inc.144.7390144.7393.750.187Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC126.5400126.5403.280.687Neu+100,0%
Monashee Investment Management LLC95.000095.0002.461.450Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC59.610059.6101.544.495Neu+100,0%
Alyeska Investment Group, L.P.57.000057.0001.476.870Neu+100,0%
TD ASSET MANAGEMENT INC47.580047.5801.232.798Neu+100,0%
AMERIPRISE FINANCIAL INC44.477044.4771.152.399Neu+100,0%
MARSHALL WACE, LLP29.348029.348760.406Neu+100,0%
BANK OF AMERICA CORP /DE/28.020028.020725.998Neu+100,0%
NORTHERN TRUST CORP20.862020.862540.534Neu+100,0%
GOLDMAN SACHS GROUP INC19.283019.283499.623Neu+100,0%
STATE STREET CORP17.250017.250446.948Neu+100,0%
MANUFACTURERS LIFE INSURANCE COMPANY, THE11.870011.870307.552Neu+100,0%
Squarepoint Ops LLC7.81107.811202.383Neu+100,0%
MORGAN STANLEY4.17904.179108.278Neu+100,0%
PRICE T ROWE ASSOCIATES INC /MD/704.4400704.44018.253Neu+100,0%
UBS Group AG455045511.789Neu+100,0%
BARCLAYS PLC14001403.627Neu+100,0%
ROYAL BANK OF CANADA850852.000Neu+100,0%

Top-Fondshalter (Stand: 31.03.2026) ⓘ

FondsAnteileVorquartal (Stk)ΔWert (USD)Anteil (%)
RA CAPITAL MANAGEMENT, L.P.8.021.1170+100,0%207.827.14132,71
NEA Management Company, LLC7.392.3010+100,0%191.534.51930,14
Sands Capital Alternatives, LLC2.500.0120+100,0%64.775.31110,19
Samsara BioCapital, LLC2.109.9530+100,0%54.668.8828,60
Vestal Point Capital, LP666.7600+100,0%17.275.7522,72
DEERFIELD MANAGEMENT COMPANY, L.P.550.0000+100,0%14.250.5002,24
JPMORGAN CHASE & CO577.1090+100,0%13.487.0372,12
MILLENNIUM MANAGEMENT LLC468.7940+100,0%12.146.4531,91
VANGUARD CAPITAL MANAGEMENT LLC434.8130+100,0%11.266.0051,77
First Light Asset Management, LLC375.0000+100,0%9.716.2501,53
FRANKLIN RESOURCES INC300.0000+100,0%7.773.0001,22
Affinity Asset Advisors, LLC250.0000+100,0%6.477.5001,02
Aberdeen Group plc220.4540+100,0%5.711.9630,90
BlackRock, Inc.144.7390+100,0%3.750.1870,59
GEODE CAPITAL MANAGEMENT, LLC126.5400+100,0%3.280.6870,52
Monashee Investment Management LLC95.0000+100,0%2.461.4500,39
CHARLES SCHWAB INVESTMENT MANAGEMENT INC59.6100+100,0%1.544.4950,24
Alyeska Investment Group, L.P.57.0000+100,0%1.476.8700,23
TD ASSET MANAGEMENT INC47.5800+100,0%1.232.7980,19
AMERIPRISE FINANCIAL INC44.4770+100,0%1.152.3990,18

Halter-Trend (6 Quartale)

PeriodeStatusHalterAnteile (Mio)Wert (Mio $)
31.03.2026✓3525,8648

Top 10 Neueinsteiger

Keine Neueinsteiger.

Top 10 Aufstocker

Keine Aufstocker.

Top 10 Verkäufer

Keine Verkaeufer.

Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →

Aktivisten & Großaktionäre (13D/13G) ⓘ

DatumInvestorTypAnteilAktienΔZweck
17.02.2026Samsara Opportunity Fund, L.P.Passiv (13G)1,90 %625.000Neu
17.02.2026Srinivas AkkarajuPassiv (13G)6,30 %2.109.953Neu
17.02.2026Samsara BioCapital GP, LLCPassiv (13G)4,50 %1.484.953Neu
17.02.2026Samsara BioCapital, L.P.Passiv (13G)4,50 %1.484.953Neu
17.02.2026Samsara Opportunity Fund GP, LLCPassiv (13G)1,90 %625.000Neu
17.02.2026Rajeev ShahAktivist (13D)24,10 %8.022.639NeuThe Reporting Persons acquired the common stock reported herein for investment purposes …
17.02.2026RA Capital Healthcare Fund, L.P.Aktivist (13D)17,90 %5.966.439NeuThe Reporting Persons acquired the common stock reported herein for investment purposes …
17.02.2026RA Capital Management, L.P.Aktivist (13D)24,10 %8.022.639NeuThe Reporting Persons acquired the common stock reported herein for investment purposes …
17.02.2026Peter KolchinskyAktivist (13D)24,10 %8.022.639NeuThe Reporting Persons acquired the common stock reported herein for investment purposes …
17.02.2026RA Capital Nexus Fund III, L.P.Aktivist (13D)6,20 %2.054.678NeuThe Reporting Persons acquired the common stock reported herein for investment purposes …
13.02.2026Sands Capital Life Sciences Pulse Fund III-Holdings, L.P.Passiv (13G)6,50 %2.079.215Neu
13.02.2026Sands Capital Alternatives, LLCPassiv (13G)1,30 %420.797Neu
13.02.2026Sands Capital Life Sciences Pulse Fund III (DE), L.P.Passiv (13G)1,30 %420.797Neu
13.02.2026SANDS FRANK M.Passiv (13G)7,80 %2.500.012Neu
13.02.2026Gilde Healthcare Holding B.V.Aktivist (13D)6,57 %2.187.513NeuThe information set forth in Item 3 of this Statement is incorporated herein by referenc…
13.02.2026Cooperatieve Gilde Healthcare VG VI U.A.Aktivist (13D)6,57 %2.187.513NeuThe information set forth in Item 3 of this Statement is incorporated herein by referenc…
13.02.2026Manapouri B.V.Aktivist (13D)6,57 %2.187.513NeuThe information set forth in Item 3 of this Statement is incorporated herein by referenc…
13.02.2026Martemanshurk B.V.Aktivist (13D)6,57 %2.187.513NeuThe information set forth in Item 3 of this Statement is incorporated herein by referenc…
13.02.2026Gilde Healthcare VG VI Management B.V.Aktivist (13D)6,57 %2.187.513NeuThe information set forth in Item 3 of this Statement is incorporated herein by referenc…
13.02.2026New Enterprise Associates 17, L.P.Aktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026Ali BehbahaniAktivist (13D)22,20 %7.393.823NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026Edward T. MathersAktivist (13D)18,10 %6.035.038NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026Forest BaskettAktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026Anthony A. Florence, Jr.Aktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026Mohamad H. MakhzoumiAktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026NEA 16 GP, LLCAktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026NEA 17 GP, LLCAktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026NEA Partners 16, L.P.Aktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026NEA Partners 17, L.P.Aktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026New Enterprise Associates 16, L.P.Aktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026Scott D. SandellAktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026Paul WalkerAktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026Carmen ChangAktivist (13D)22,20 %7.392.301NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
13.02.2026Rick YangAktivist (13D)18,10 %6.035.038NeuThe Funds acquired the Firm Shares for investment purposes. Depending on market conditio…
10.02.2026Vensana Capital I, L.P.Aktivist (13D)9,90 %3.310.619NeuThe information set forth in Item 3 of this Statement is incorporated herein by referenc…
10.02.2026Kirk NielsenAktivist (13D)9,90 %3.312.141NeuThe information set forth in Item 3 of this Statement is incorporated herein by referenc…
10.02.2026Peter Justin KleinAktivist (13D)9,90 %3.310.619NeuThe information set forth in Item 3 of this Statement is incorporated herein by referenc…
10.02.2026Vensana Capital I GP, LLCAktivist (13D)9,90 %3.310.619NeuThe information set forth in Item 3 of this Statement is incorporated herein by referenc…

Stammdaten

SpyGlass Pharma, Inc. ist ein Biopharmaunternehmen in fortgeschrittener Phase, das sich mit der Entwicklung eines Behandlungsparadigmas für Patienten mit chronischen Augenkrankheiten befasst. Sein Hauptproduktkandidat, das Bimatoprost Drug Pad-IOL System (BIM-IOL System), soll während einer routinemäßigen Kataraktoperation eingesetzt werden, um den erhöhten Augeninnendruck (IOP) bei Patienten mit offenem Winkelglaukom (OAG) oder okularer Hypertonie (OHT) zu senken. Das Unternehmen wurde im Januar 2019 von Malik Y. Kahook und Glenn Sussman gegründet und hat seinen Hauptsitz in Aliso Viejo, CA.

Unternehmen & Branche

NameSpyGlass Pharma, Inc.
TickerSGP
CIK0001778922
BoerseNasdaq
SektorHealthcare
IndustrieBiotechnology
SIC3841 · Surgical & Medical Instruments & Apparatus

Wertpapier & Kennzahlen

CUSIP85220G109
ISINUS85220G1094
TypCommon Stock
Marktkapitalisierung40,6 Mio. USD

Bewertung

FCF-Rendite-82,4 %
Buyback-Rendite3,6 %

Qualität & Bilanz

Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2024. Kennzahlen erklärt →

Externe Quelle: SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »

Finanzkennzahlen (SEC XBRL) ⓘ

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2026-03-3110-Q-13.818.000-0,69258.386.000250.112.000
2025-12-3110-K-39.869.000-17,98115.866.000-98.837.000
2025-03-3110-Q-8.823.000-3,96-68.852.000
2024-12-3110-K-29.164.000-16,3123.318.000-60.474.000

Quartalsergebnisse (Earnings) ⓘ

QuartalStichtagVerkündetUmsatzEPS
Q1 202631.03.202614.05.2026–-0,69
Q1 202531.03.202514.05.2026–-3,96

Einreichungs-Historie (10-K / 10-Q)

SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte (10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die Tage zwischen Berichtsstichtag und tatsächlicher Einreichung. Suffix /A kennzeichnet nachträgliche Berichtigungen.

Eingereicht Form Berichtsperiode Verzögerung
14.05.2026 10-Q – – SEC »
26.03.2026 10-K 31.12.2025 85 Tage SEC »

Kritische 8-K Meldungen ⓘ

DatumMeldungSchwereFilingAuszug
13.02.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSEC13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment…

Fail-to-Deliver (6 Monate) ⓘ

DatumFTD-MengeKursWert (USD)
2026-05-271920,62392
2026-05-2010221,202.162
2026-05-19222,2444
2026-05-1464723,8215.412
2026-05-1280023,7619.008
2026-05-071225,06301
2026-05-0120622,944.726
2026-04-29123,0023
2026-04-2847923,6511.328
2026-04-231.45224,4935.559
2026-04-2165624,5216.085
2026-04-171.58925,0339.773
2026-04-161.13124,7327.970
2026-04-154624,521.128
2026-04-141.10423,8726.352
2026-04-133.10420,7564.408
2026-04-014.58325,91118.746
2026-03-311.37223,3732.064
2026-03-3048.29322,611.091.905
2026-03-2752.24625,201.316.599
2026-03-265.88025,22148.294
2026-03-2527.11623,74643.734
2026-03-249926,352.609
2026-03-2321.71526,00564.590
2026-03-202.31225,7159.442
2026-03-1910026,802.680
2026-03-181.65827,2045.098
2026-03-172.69627,1073.062
2026-03-1337026,429.775
2026-03-1274627,1020.217
2026-03-091.42426,6837.992
2026-03-06126,4226
2026-02-115027,831.392
2026-02-093.22526,4085.140

Hinweis

Erweitert ×